These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31033908)

  • 21. Multidrug-resistant Acinetobacter baumannii ventriculitis: successful treatment with intraventricular colistin.
    López-Alvarez B; Martín-Láez R; Fariñas MC; Paternina-Vidal B; García-Palomo JD; Vázquez-Barquero A
    Acta Neurochir (Wien); 2009 Nov; 151(11):1465-72. PubMed ID: 19424656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin.
    Fotakopoulos G; Makris D; Chatzi M; Tsimitrea E; Zakynthinos E; Fountas K
    Acta Neurochir (Wien); 2016 Mar; 158(3):603-10; discussion 610. PubMed ID: 26801512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection.
    Deng ZW; Wang J; Qiu CF; Yang Y; Shi ZH; Zhou JL
    Medicine (Baltimore); 2019 Apr; 98(15):e15139. PubMed ID: 30985683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
    Ozbek B; Sentürk A
    Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraventricular versus intravenous colistin for the treatment of extensively drug resistant Acinetobacter baumannii meningitis.
    De Bonis P; Lofrese G; Scoppettuolo G; Spanu T; Cultrera R; Labonia M; Cavallo MA; Mangiola A; Anile C; Pompucci A
    Eur J Neurol; 2016 Jan; 23(1):68-75. PubMed ID: 26228051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraventricular polymyxin B for the treatment of neonatal meningo-ventriculitis caused by multi-resistant Acinetobacter baumannii--case report and review of literature.
    Piparsania S; Rajput N; Bhatambare G
    Turk J Pediatr; 2012; 54(5):548-54. PubMed ID: 23427525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug-resistant Klebsiella oxytoca ventriculitis, successfully treated with intraventricular tigecycline: A case report.
    Soto-Hernández JL; Soto-Ramírez A; Pérez-Neri I; Angeles-Morales V; Cárdenas G; Barradas VA
    Clin Neurol Neurosurg; 2020 Jan; 188():105592. PubMed ID: 31760254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR
    Pan S; Huang X; Wang Y; Li L; Zhao C; Yao Z; Cui W; Zhang G
    Antimicrob Resist Infect Control; 2018; 7():8. PubMed ID: 29387342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas.
    Paramythiotou E; Karakitsos D; Aggelopoulou H; Sioutos P; Samonis G; Karabinis A
    Med Mal Infect; 2007 Feb; 37(2):124-5. PubMed ID: 17270377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of ventriculoperitoneal shunt infection and ventriculitis caused by Acinetobacter baumannii: a case report.
    Demoz GT; Alebachew M; Legesse Y; Ayalneh B
    J Med Case Rep; 2018 May; 12(1):141. PubMed ID: 29788980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report.
    Tekçe AY; Erbay A; Çabadak H; Yağcı S; Karabiber N; Şen S
    Surg Infect (Larchmt); 2011 Apr; 12(2):141-3. PubMed ID: 21348768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia.
    Zeng J; Zhang L; Gao M; Wu J; Wu H; Chen J; Chen X; Tang W
    Int J Infect Dis; 2017 Aug; 61():23-26. PubMed ID: 28572073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.
    Khawcharoenporn T; Apisarnthanarak A; Mundy LM
    Clin Microbiol Infect; 2010 Jul; 16(7):888-94. PubMed ID: 19686281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged and high dosage of tigecycline - successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report.
    Tsachouridou O; Georgiou A; Nanoudis S; Chrysanthidis T; Loli G; Morfesis P; Zebekakis P; Metallidis S
    J Med Case Rep; 2017 Jul; 11(1):186. PubMed ID: 28687078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidrug Resistant Brain Abscess Due to
    Long W; Yuan J; Liu J; Liu J; Wu M; Chen X; Peng G; Wu C; Zhang C; Wang X; Zhao W; Liu Q
    Front Neurol; 2018; 9():518. PubMed ID: 30026723
    [No Abstract]   [Full Text] [Related]  

  • 38. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
    Cakirlar FK; Ciftci IH; Gonullu N
    Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 21st-century challenge to neurocritical care: the rise of the superbug Acinetobacter baumannii. A meta-analysis of the role of intrathecal or intraventricular antimicrobial therapy in reduction of mortality.
    Mohammed N; Savardekar AR; Patra DP; Narayan V; Nanda A
    Neurosurg Focus; 2017 Nov; 43(5):E8. PubMed ID: 29088961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Ricciardi R; Ricciardi AM; Danzi G
    Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.